ETF Managers Group, LLC Novo Cure LTD Transaction History

ETF Managers Group, LLC

$2.78 Billion
Q1 2023

A detailed history of ETF Managers Group, LLC transactions in Novo Cure LTD stock. As of the latest transaction made, ETF Managers Group, LLC holds 51,133 shares of NVCR stock, worth $862,102. This represents 0.11% of its overall portfolio holdings.

Number of Shares

51,133

Holding current value

$862,102

% of portfolio

0.11%

22 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 Apr 17, 2023	BUY	$56.44 - $118.81 $2.89 Million - $6.08 Million	51,133 New	51,133 $3.08 Million
Q3 2022 Nov 14, 2022	BUY	$67.99 - $89.57 $253,194 - $333,558	3,724 Added 8.16%	49,367 $3.75 Million
Q2 2022 Aug 15, 2022	SELL	$56.6 - $89.9 $851,943 - $1.35 Million	-15,052 Reduced 24.8%	45,643 $3.31 Million
Q1 2022 May 13, 2022	SELL	$60.15 - $84.52 $286,314 - $402,315	-4,760 Reduced 7.27%	60,695 $5.1 Million
Q4 2021 Feb 14, 2022	SELL	$75.08 - $121.99 $258,500 - $420,011	-3,443 Reduced 5.0%	65,455 $5.23 Million
Q3 2021 Nov 15, 2021	SELL	$116.17 - $194.55 $551,575 - $923,723	-4,748 Reduced 6.45%	68,898 $8 Million
Q2 2021 Aug 16, 2021	SELL	$130.4 - $225.58 $1.26 Million - $2.18 Million	-9,646 Reduced 11.58%	73,646 $16.5 Million
Q1 2021 May 17, 2021	BUY	$124.11 - $190.17 $1.85 Million - $2.83 Million	14,875 Added 21.74%	83,292 $10.4 Million
Q4 2020 Feb 16, 2021	SELL	$112.16 - $174.14 $3.38 Million - $5.25 Million	-30,172 Reduced 30.6%	68,417 $11.9 Million
Q3 2020 Nov 16, 2020	BUY	$58.05 - $111.31 $445,127 - $853,525	7,668 Added 8.43%	98,589 $10.7 Million
Q2 2020 Aug 14, 2020	BUY	$57.2 - $74.41 $407,149 - $529,650	7,118 Added 8.49%	90,921 $5.25 Million
Q1 2020 May 14, 2020	BUY	$57.05 - $95.75 $424,908 - $713,146	7,448 Added 9.75%	83,803 $5.87 Million
Q4 2019 Feb 14, 2020	BUY	$68.3 - $93.8 $546,741 - $750,869	8,005 Added 11.71%	76,355 $6.51 Million
Q3 2019 Nov 14, 2019	BUY	$61.86 - $97.8 $445,392 - $704,160	7,200 Added 11.77%	68,350 $5.02 Million
Q2 2019 Aug 14, 2019	BUY	$42.22 - $63.23 $432,248 - $647,348	10,238 Added 20.11%	61,150 $3.72 Million
Q1 2019 May 07, 2019	SELL	$31.96 - $56.12 $155,805 - $273,585	-4,875 Reduced 8.74%	50,912 $2.45 Million
Q4 2018 Feb 01, 2019	BUY	$28.72 - $52.63 $98,222 - $179,994	3,420 Added 6.53%	55,787 $1.87 Million
Q3 2018 Nov 14, 2018	BUY	$32.0 - $52.4 $1.68 Million - $2.74 Million	52,367 New	52,367 $2.74 Million
Q2 2018 Aug 14, 2018	SELL	$19.85 - $32.0 $814,822 - $1.31 Million	-41,049 Closed	0 $0
Q1 2018 May 15, 2018	BUY	$19.3 - $23.65 $130,468 - $159,874	6,760 Added 19.71%	41,049 $835,000
Q4 2017 Feb 14, 2018	BUY	$16.3 - $21.9 $145,542 - $195,545	8,929 Added 35.21%	34,289 $696,000
Q3 2017 Nov 14, 2017	BUY	$18.05 - $21.75 $457,748 - $551,580	25,360	25,360 $503,000

Others Institutions Holding NVCR

# of Institutions

262

Shares Held

77M

Call Options Held

1.17M

Put Options Held

318K

View Full List

About NovoCure Ltd

Ticker NVCR
Exchange NASDAQ
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 104,950,000
Market Cap $1.77B
Description
NovoCure Limited, an oncology company, engages in the development, manufacture, and commercialization of tumor treating fields (TTFields) devices for the treatment of solid tumor cancers in the United States, Europe, the Middle East, Africa, Japan, and Greater China. Its TTFields devices include Optune for the treatment of glioblastoma; and Optu...

More about NVCR

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of ETF Managers Group, LLC, based on Form 13F filings with the SEC.

News

Stay updated on ETF Managers Group, LLC with notifications on news.

Account

ETF Managers Group, LLC Novo Cure LTD Transaction History